BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28265826)

  • 1. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Carr RM; Patel A; Bownik H; Oranu A; Kerner C; Praestgaard A; Forde KA; Reddy KR; Lichtenstein GR
    Dig Dis Sci; 2017 May; 62(5):1354-1361. PubMed ID: 28265826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
    Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
    World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
    Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
    [No Abstract]   [Full Text] [Related]  

  • 4. Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review.
    Spagnuolo R; Abenavoli L; Corea A; Larussa T; Mancina RM; Cosco C; Luzza F; Doldo P
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5818-5825. PubMed ID: 34604973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Ritaccio G; Stoleru G; Abutaleb A; Cross RK; Shetty K; Sakiani S; Wong U
    Dig Dis Sci; 2021 Sep; 66(9):3186-3191. PubMed ID: 32894439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B
    J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Principi M; Iannone A; Losurdo G; Mangia M; Shahini E; Albano F; Rizzi SF; La Fortezza RF; Lovero R; Contaldo A; Barone M; Leandro G; Ierardi E; Di Leo A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1589-1596. PubMed ID: 29688336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Noorian S; Jeon Y; Nguyen MT; Sauk J; Limketkai BN
    Inflamm Bowel Dis; 2022 Jun; 28(6):878-887. PubMed ID: 34374782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Aggarwal M; Garg R; Parthasarthy G; Nowacki AS; Padival R; McCullough A; Qazi T; Click B; Rieder F; Cohen BL
    Dig Dis Sci; 2023 Mar; 68(3):1006-1015. PubMed ID: 35731428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.
    Glassner K; Malaty HM; Abraham BP
    Inflamm Bowel Dis; 2017 Jun; 23(6):998-1003. PubMed ID: 28511199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.
    Sartini A; Gitto S; Bianchini M; Verga MC; Di Girolamo M; Bertani A; Del Buono M; Schepis F; Lei B; De Maria N; Villa E
    Cell Death Dis; 2018 Jan; 9(2):87. PubMed ID: 29367619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of non-alcoholic fatty liver disease in patients with Crohn's disease but not ulcerative colitis.
    Li D; Lu C; Yu C
    Int J Clin Exp Pathol; 2017; 10(10):10633-10639. PubMed ID: 31966406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    Yen HH; Su PY; Huang SP; Wu L; Hsu TC; Zeng YH; Chen YY
    PLoS One; 2021; 16(5):e0252286. PubMed ID: 34043691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
    Cho KI; Jo EA; Cho SH; Kim BH
    Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
    Saroli Palumbo C; Restellini S; Chao CY; Aruljothy A; Lemieux C; Wild G; Afif W; Lakatos PL; Bitton A; Cocciolillo S; Ghali P; Bessissow T; Sebastiani G
    Inflamm Bowel Dis; 2019 Jan; 25(1):124-133. PubMed ID: 29889226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.
    Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L
    Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Zamani M; Alizadeh-Tabari S; Singh S; Loomba R
    Aliment Pharmacol Ther; 2022 Apr; 55(8):894-907. PubMed ID: 35274325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease.
    Hyun HK; Lee HW; Park J; Park SJ; Park JJ; Kim TI; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU; Cheon JH
    Gut Liver; 2024 Mar; 18(2):294-304. PubMed ID: 37203442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.